14 julio 2015
The investigational drug patiromer quickly reduced elevated blood-potassium levels — a common life-threatening side effect of treatment for chronic diabetic kidney disease. In this year-long study of more than 300 patients, patiromer kept potassium levels under control for the length of the trial.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/ERMzFES0F0I» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ERMzFES0F0I/150714113033.htm
